Centre for Advanced BioProduction,(AdBIOPRO),phase 2
| Reference number | |
| Coordinator | Kungliga Tekniska Högskolan - Kungliga Tekniska Högskolan Skolan f kemi bioteknologi & hälsa |
| Funding from Vinnova | SEK 36 000 000 |
| Project duration | November 2022 - October 2027 |
| Status | Ongoing |
| Venture | Competence centre |
Purpose and goal
The vision of AdBIOPRO is to be an internationally leading, sustainable and dynamic centre for research on advanced bioproduction, outstanding in quality, industrially anchored and geared to offer its partners cutting edge advantages in terms of technology, knowledge and competence. Through the synergy of its multi-disciplinary teams, AdBIOPRO creates competitive technology for therapeutic biologics bioproduction and in particular to the new trends towards ATMPs and continuous bioprocessing.
Expected effects and result
AdBIOPRO will take an internationally leading role in the field. Strong collaborations will sustainably take place within AdBIOPRO generating new technologies, young highly qualified researchers and engineers, mobility between academia and industry, and strategic contacts.
Planned approach and implementation
AdBIOPRO omfattar 9 akademiska team från KTH, Lunds universitet, Karolinska Universitetssjukhuset, Karolinska Institutet och Linköpings universitet samt 17 industriella partners, Alfa Laval, ArgusEye, AstraZeneca, BioInvent, BioLamina, CellColabs, Cellevate, Cytiva, Erbi biosystems, MAGic Bioprocessing, Metenova, NorthX Biologics, Nyctea, TimeGate, Valneva, Xbrane och XNK Therapeutics. AdBIOPRO är inriktat mot nyckelaspekter för biomanufacturing av terapeutiska produkter på ett tvärvetenskapligt sätt, med starkt fokus på industriell tillämpbarhet.